Echocardiographic hemodynamics correlate with differences in DOAC-specific bleeding and stroke rates in non-valvular atrial fibrillation
Elevated RVSP is associated with excess bleeding in patients taking rivaroxaban and dabigatran, but not apixaban, after controlling for confounding variables.
Authors
- Srekar Ravi (ORCID: https://orcid.org/0000-0002-0312-6958)
- Chadi Ayoub (ORCID: https://orcid.org/0000-0001-5877-7478)
- Hicham El Masry (ORCID: https://orcid.org/0000-0002-2470-2862)
- Pradyumna Agasthi (ORCID: https://orcid.org/0000-0003-3067-6979)
- Timothy Barry (ORCID: https://orcid.org/0000-0002-0576-2990)
- Eiad Habib (ORCID: https://orcid.org/0000-0003-4708-0039)
- Suganya Arunachalam Karikalan (ORCID: https://orcid.org/0000-0003-2746-3710)
- Sam Newton (ORCID: https://orcid.org/0000-0002-6915-9007)
- Hasan Ashraf (ORCID: https://orcid.org/0000-0002-3808-6933)
- Michael P. O’Shea
- Ali Yusuf
- Chieh Ju Chao
- Robert L. Scott
- Reza Arsanjani
Institutions
- Sanford Health (US)
- Palo Alto University (US)
- Christus Health (US)
- Kwame Nkrumah University of Science and Technology (GH)
- London School of Hygiene & Tropical Medicine (GB)
- Mayo Clinic in Arizona (US)
- Stanford University (US)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1186/s12872-025-05239-w
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- London School of Hygiene and Tropical Medicine